Cargando…
Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States
(See the editorial commentary by Jain et al, on pages 707–709.) Background. Peramivir, an investigational intravenous neuraminidase inhibitor in Phase 3 trials for hospitalized patients, was made available during the 2009 H1N1 influenza pandemic under the Emergency Investigational New Drug (eIND) re...
Autores principales: | Hernandez, Jaime E., Adiga, Raghavendra, Armstrong, Robert, Bazan, Jose, Bonilla, Hector, Bradley, John, Dretler, Robin, Ison, Michael G., Mangino, Julie E., Maroushek, Stacene, Shetty, Avinash K., Wald, Anna, Ziebold, Christine, Elder, Jenna, Hollister, Alan S., Sheridan, William |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049340/ https://www.ncbi.nlm.nih.gov/pubmed/21367722 http://dx.doi.org/10.1093/cid/cir001 |
Ejemplares similares
-
827 The efficacy of single dose peramivir in acute uncomplicated influenza: an integrated subject-level meta-analysis
por: Whitley, Richard, et al.
Publicado: (2014) -
Peramivir injection in the treatment of acute influenza: a review of the literature
por: Wester, Ashley, et al.
Publicado: (2016) -
Peramivir for influenza
Publicado: (2019) -
Safety and efficacy of peramivir for influenza treatment
por: Hata, Atsuko, et al.
Publicado: (2014) -
A Case Report of Listeria monocytogenes Meningitis in a Child With Hyper-IgM Syndrome in a Resource-Limited Setting
por: Alao, Michael Abel, et al.
Publicado: (2019)